Literature DB >> 28845580

Comparison of extracardiac conduit and lateral tunnel for functional single-ventricle patients: A meta-analysis.

Zhiyong Lin1, Hanwei Ge1, Jiyang Xue1, Guowei Wu1, Jie Du1, Xingti Hu1, Qifeng Zhao1.   

Abstract

OBJECTIVE: This study aims to assess and compare the early and long-term effects of extracardiac conduit (EC) and lateral tunnel (LT) in patients with a functional single ventricle through meta-analysis.
DESIGN: A systematic search was performed in PubMed, Embase, Cochrane Library, CNKI, VIP, CBM, and WanFang databases for papers that were published until August 1, 2016. Cochrane systematic review method was used for paper screening and information retrieve, and RevMan 5.3 software was applied for the meta-analysis.
RESULTS: Data for 10 studies with a total of 3814 patients were retrieved. The advantages of EC comparing to LT include: lower 30 day postsurgery supraventricular arrhythmia incidence (Relative Risk [RR] = 0.31 [0.17, 0.55], P < .001), lower protein loss enteropathy incidence (RR = 0.33 [0.11, 0.96], P = .04), and requiring no cardiopulmonary bypass. However, the chest drainage time was longer (mean difference [MD] = 1.99 [1.83, 2.15], P < .001) in EC. There were no significant differences in early postoperative mortality, long-term mortality, long-term arrhythmia, Fontan takedown, ventilator-assisted ventilation, ICU stay, thrombosis, pleural effusion, and pericardial effusion between EC and LT.
CONCLUSIONS: EC had a lower incidence of supraventricular arrhythmia (30 days after operation) and the rate of protein losing enteropathy than LT, and requiring no cardiopulmonary bypass. These show that EC has an advantage over the LT in patients with a functional single ventricle.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fontan procedure; extracardiac conduit; functional single ventricle; lateral tunnel

Mesh:

Year:  2017        PMID: 28845580     DOI: 10.1111/chd.12503

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  3 in total

1.  The Fontan Pathway: Change in Dimension and Catheter-Based Intervention over Time.

Authors:  E McGovern; T Alsaied; N Szugye; S Pradhan; S P Batlivala; A Lubert; R Hirsch
Journal:  Pediatr Cardiol       Date:  2021-06-16       Impact factor: 1.655

2.  Hypoplastic left heart syndrome: current modalities of treatment and outcomes.

Authors:  Smruti Ranjan Mohanty; Agastya Patel; Simran Kundan; Hari Bipin Radhakrishnan; Suresh Gururaja Rao
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-03-11

Review 3.  State of the art of the Fontan strategy for treatment of univentricular heart disease.

Authors:  Jelle P G van der Ven; Eva van den Bosch; Ad J C C Bogers; Willem A Helbing
Journal:  F1000Res       Date:  2018-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.